Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis.
D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002241:Carbohydrates / Q000097:blood; D002245:Carbon Dioxide / Q000032:analysis*; D016883:Diabetic Ketoacidosis / Q000097:blood / Q000628:therapy*; D004573:Electrolytes / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000097:blood / Q000627:therapeutic use*; D007657:Ketone Bodies / Q000652:urine; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000652:urine*; D010100:Oxygen / Q000032:analysis*; D010101:Oxygen Consumption; D012119:Respiration
D000596:Amino Acids; D001786:Blood Glucose; D002241:Carbohydrates; D004573:Electrolytes; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007657:Ketone Bodies; D002245:Carbon Dioxide; D005934:Glucagon; D009584:Nitrogen; D010100:Oxygen